- ROUNDTABLE: Improving patient outcomes, controlling costs with OTCs
- Study: 2,000 IUs of vitamin E daily effective in slowing functional decline in AD patients
- Report: Dietary supplements utilized as preventive health care can save health system tens of billions of dollars
- Abbott launches Glucerna Advance RTD to provide nutritional benefits for those with diabetes
- Lumene unveils product innovation, new packaging for 2014
SILVER SPRING, Md. — Pharmagen on Thursday announced the launch of Clotamin, a unique multivitamin formulated without vitamin K in order to meet the special nutritional needs of people taking blood-thinning medications (anticoagulants), such as Warfarin.
Because it does not contain vitamin K, Clotamin can be taken with Warfarin without affecting international normalized ratio levels.
Warfarin is the most prescribed blood thinning medication in North America — the therapy helps to reduce the formation of blood clots, which is important in the prevention of heart attacks, strokes, and blockage of major veins and arteries.
Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.